<?xml version="1.0" encoding="UTF-8"?>
<p id="p0585" num="0585" sourceFile="EP 1828185B1.xml">The title compound was prepared from aniline and 
  <i>N</i>-{3-[3-(2-chloro-4-pyrimidinyl)-pyrazolo[1,5-b]pyridin-2-yl]phenyl}-1-methyl-1H-pyrrole-2-carboxamide in a manner analogous to 
  <b>Example 27</b>, Step D. 
  <sup>1</sup>H NMR (400 MHz, DMSO-d
  <sub>6</sub>) δ 3.90 (s, 3H), 6.13 (dd, 1H, J = 2.7, 4.8 Hz), 6.58 (d, 1H, J = 5.3 Hz), 6.98-7.09 (m, 3H), 7.17 (t, 1H, J = 5.3 Hz), 7.27-7.32 (m, 3H), 7.47 (t, 1H, J = 8.0 Hz), 7.53 (d, 1H, J = 7.2 Hz), 7.75 (d, 2H, J = 7.8 Hz), 7.92 (d, 1H, J = 8.0 Hz), 8.10 (s, 1 H), 8.29 (d, 1 H, J = 5.3 Hz),
  <!-- EPO <DP n="155"> --> 8.55 (d, 1H, J = 9.0 Hz), 8.88 (d, 1 H, J = 6.9 Hz), 9.63 (s, 1H), 9.92 (s, 1H); ESIMS (M+H)
  <sup>+</sup> = 486.
</p>
